Circulating Diagnostic Markers of Infectious Disease

Assays for accurate diagnosis of early stages of infection with biothreat agents, on the day of infection or within a few days of infection, will find wide use in both civilian and military applications These diagnostic assays, which are anticipated to be highly specific and sensitive, will add to the repertoire of tools of hospitals and clinics that serve our armed forces personnel deployed on the front lines in diverse geographical regions of the globe, as well infectious disease clinics that cater to civilian populations world-wide. In addition, such assays for early accurate diagnosis of infections caused by the above biothreat agents with the ability to wreak havoc in both humans and animals, will be very attractive for organizations involved in surveillance efforts for prompt and effective management of infections caused by these pathogens. The commercial market for such dual use diagnostic assays is therefore expected to be global.